claire_mitchell

Acute Oncology Pathway Clinical Director – Dr Claire Mitchell

Find out more about Claire


shutterstock_289559267 2Pathway Board membership

See the current membership


To see earlier minutes/papers – click here

Pathway Board Meetings:

Cancer of unknown primary sub-group meeting

Education sub-group meeting

Metastatic spinal cord compression meeting


Pathway Board documents


Acute oncology minimum dataset


Acute oncology clinical guidelines

Please note: The information contained in these guidelines are based on the UKONS clinical guidelines and provide a consensus on the management of oncological complications. Clinicians using these documents are expected to use independent clinical judgment in the context of the presenting clinical circumstances to determine any patient’s care or treatment.

These are guidelines only and local policies should be followed in the management of patients; these guidelines can however be used as a basis for the development of local policy.

*The guidelines below were developed and agreed in March 2015 at the Manchester Cancer Acute Oncology Pathway Board and will be reviewed every 2 years

  1. MC Management of Hypomagnesaemia
  2. MC Management Pathway for Acute Cerebral _ other CNS Oedema and Cerebral Space Occupying Lesion
  3. MC Management Pathway for Anaphylaxsis
  4. MC Management Pathway for Ascites
  5. MC Management Pathway for Carcinomatosis Lymphangitis
  6. MC Management Pathway for Chemotherapy Induced Skin Reactions
  7. MC Management Pathway for Chemotherapy Radiotherapy Nausea and Vomiting
  8. MC Management Pathway for Complications of CVAD
  9. MC Management Pathway for Diarrhoea
  10. MC Management Pathway for Extravasation
  11. MC Management Pathway for Malignant Hypercalcaemia
  12. MC Management Pathway for Mucositis
  13. MC Management Pathway for Palmar Planter Erythrodysaethesia
  14. MC Management Pathway for Pericardial Effusion
  15. MC Management Pathway for Pleural Effusion
  16. MC Management Pathway for Radiation Pneumonitis
  17. MC Management Pathway for Radiation Skin Reactions
  18. MC Management Pathway for Superiour Vena Cava Obstruction
  19. MC Treatment Pathway Document
  20. MC Neutropenic Sepsis Pathway
  21. UKONS FINAL_GUIDELINE_V_1 0_11

CUP guidelines

  1. MC Management Pathway for MUO CUP
  2. Network CUP guidelines 2016

MSCC guidelines

Metastatic Spinal Cord Compression (MSCC)

People with cancer are at risk of this spreading to other parts of their body, including the spine.  Spinal metastases can be painful and if not treated can lead to metastatic spinal cord compression (MSCC) – this is when the spinal metastases press on the nerves in the spine. MSCC is rare, but it can cause damage to the spinal cord and can lead to permanent paralysis and requires urgent diagnosis and treatment (NICE 2008).

If you are a patient and you are concerned about symptoms suggesting Metastatic Spinal Cord Compression please see your GP, Oncologist or Specialist Nurse urgently. If you are a clinician, contact the MSCC Co-ordinating Service, also urgently, based at The Christie www.christie.nhs.uk/MSCC.